Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophilsHORVATH, C. J; FERRO, T. J; JESMOK, G et al.Proceedings of the National Academy of Sciences of the United States of America. 1988, Vol 85, Num 23, pp 9219-9223, issn 0027-8424Article

Immunoassays for human tumour necrosis factors alpha and betaMEAGER, A; LEUNG, H; WOOLLEY, J et al.Developments in biological standardization. 1988, Vol 69, issn 0301-5149, 153Conference Paper

A Distinct Role for Transient Receptor Potential Ankyrin 1, in Addition to Transient Receptor Potential Vanilloid 1, in Tumor Necrosis Factor α―Induced Inflammatory Hyperalgesia and Freund's Complete Adjuvant―Induced MonarthritisFERNANDES, Elizabeth S; RUSSELL, Fiona A; BEVAN, Stuart et al.Arthritis and rheumatism. 2011, Vol 63, Num 3, pp 819-829, issn 0004-3591, 11 p.Article

The Cytomegaloviral Protein pUL138 Acts as Potentiator of Tumor Necrosis Factor (TNF) Receptor 1 Surface Density To Enhance ULb'-Encoded Modulation of TNF-α SignalingVU THUY KHANH LE; TRILLING, Mirko; HENGEL, Hartmut et al.Journal of virology. 2011, Vol 85, Num 24, pp 13260-13270, issn 0022-538X, 11 p.Article

Tumor necrosis factor (TNF)-α-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptorsFRISHMAN, Jordan I; EDWARDS, Carl K; SONNENBERG, Michael G et al.The Journal of infectious diseases. 2000, Vol 182, Num 6, pp 1722-1730, issn 0022-1899Article

Crystallization of human tumour necrosis factorWALKER, N; MARCINOWSKI, S; HILLEN, H et al.Journal of crystal growth. 1990, Vol 100, Num 1-2, pp 168-170, issn 0022-0248, 3 p.Article

Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journeyAGGARWAL, Bharat B; GUPTA, Subash C; JI HYE KIM et al.Blood. 2012, Vol 119, Num 3, pp 651-665, issn 0006-4971, 15 p.Article

Non-TNF-Biologika in der Therapie : Was kommt nach TNF-Blockern im klinischen Alltag ? = Non-TNF biologicals in therapy : What comes after TNF-blockers in clinical routine ?WOLLENHAUPT, J; BURMESTER, G.-R.Zeitschrift für Rheumatologie (Print). 2010, Vol 69, Num 7, pp 579-580, issn 0340-1855, 2 p.Article

Regulation of the pathophysiology of tumor necrosis factorDEFORGE, L. E; NGUYEN, D. T; KUNKEL, S. L et al.The Journal of laboratory and clinical medicine. 1990, Vol 116, Num 4, pp 429-438, issn 0022-2143Article

Refractory ulcers: The role of tumor necrosis factor—aWEINSTEIN, David A; KIRSNER, Robert S.Journal of the American Academy of Dermatology. 2010, Vol 63, Num 1, pp 146-154, issn 0190-9622, 9 p.Article

Overexpression of tumor necrosis factor causes bilateral sacroiliitisREDLICH, Kurt; GÖRTZ, Birgit; HAYER, Silvia et al.Arthritis and rheumatism. 2004, Vol 50, Num 3, pp 1001-1005, issn 0004-3591, 5 p.Article

The utility of tumour necrosis factor blockade in orphan diseasesKEYSTONE, E. C.Annals of the rheumatic diseases. 2004, Vol 63, pp ii79-ii83, issn 0003-4967, SUP2Article

Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surfaceRYAN, J; BRETT, J; TIJBURG, P et al.Blood. 1992, Vol 80, Num 4, pp 966-974, issn 0006-4971Article

Tumor necrosis factor and septic shockBAUD, L; CADRANEL, J; OFFENSTADT, G et al.Critical care medicine. 1990, Vol 18, Num 3, pp 349-350, issn 0090-3493Article

Cachectin/tumour necrosis factor-α in the circulation of patients with rheumatic diseaseMAURY, C. P. J; TEPPO, A.-M.International journal of tissue reactions. 1989, Vol 11, Num 4, pp 189-193, issn 0250-0868, 5 p.Article

Anti-tumour necrosis factor agents and lipid profile : a class effect?GARCES, S. P; PARREIRA SANTOS, M. J; VINAGRE, F. M. R et al.Annals of the rheumatic diseases. 2008, Vol 67, Num 6, pp 895-896, issn 0003-4967, 2 p.Article

Tumour necrosis factor inhibitorsNASH, Peter T; FLORIN, Timothy H. J.Medical journal of Australia. 2005, Vol 183, Num 4, pp 205-208, issn 0025-729X, 4 p.Article

Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome : interrelations with cellular sources and patterns of soluble immune mediator expressio nPATARCA, R; KLIMAS, N. G; LUGTENDORF, S et al.Clinical infectious diseases. 1994, Vol 18, pp S147-S153, issn 1058-4838, SUP1Conference Paper

Tumor necrosis factor causes amplification of arachidonic acid metabolism in response to interleukin 1, bradykinin, and other agonistsBURCH, R. M; TIFFANY, C. W.Journal of cellular physiology. 1989, Vol 141, Num 1, pp 85-89, issn 0021-9541, 5 p.Article

Effect of the polymorphisms of tumor necrosis factor-α gene on the susceptibility to primary biliary cirrhosis: a meta-analysisBAODONG QIN; YAN LIANG; ZAIXING YANG et al.European journal of gastroenterology & hepatology. 2012, Vol 24, Num 12, pp 1386-1392, issn 0954-691X, 7 p.Article

Increased voluntary exercise in mice deficient for tumour necrosis factor-α and lymphotoxin-αNETEA, M. G; KULLBERG, B. J; VONK, A. G et al.European journal of clinical investigation. 2007, Vol 37, Num 9, pp 737-741, issn 0014-2972, 5 p.Article

Role of tumor necrosis factor-α in myocardial dysfunction and apoptosis during hindlimb ischemia and reperfusionXIANGRU LU; HAMILTON, Joel A; JI SHEN et al.Critical care medicine. 2006, Vol 34, Num 2, pp 484-491, issn 0090-3493, 8 p.Article

Should We Consider Tumor Necrosis Factor as the Only Target in Spondyloarthritides?FERRACCIOLI, Gianfranco; GREMESE, Elisa.Journal of rheumatology. 2012, Vol 39, pp 94-96, issn 0315-162X, 3 p., SUP89Conference Paper

The tumor necrosis factor type 2 receptor plays a protective role in tumor necrosis factor-α-induced bone resorption lacunae on mouse calvariaeNAGANO, Kenichi; ALLES, Neil; MIAN, Anower Hussain et al.Journal of bone and mineral metabolism (English ed.). 2011, Vol 29, Num 6, pp 671-681, issn 0914-8779, 11 p.Article

Association of tumor necrosis factor-α polymorphisms and ozone-induced change in lung functionYANG, Ian A; HOLZ, Olaf; JÖRRES, Rudolf A et al.American journal of respiratory and critical care medicine. 2005, Vol 171, Num 1, pp 171-176, issn 1073-449X, 6 p.Article